open access

Vol 8, No 3 (2023)
Letter to the Editor
Published online: 2023-07-13
Get Citation

C-reactive protein and other biomarkers for diagnosis and prognosis in COVID-19

Nicola Luigi Bragazzi1, Karolina Czerwiec2, Weronika Popow2, Urszula Szafranska2
DOI: 10.5603/DEMJ.a2023.0023
·
Disaster Emerg Med J 2023;8(3):187-188.
Affiliations
  1. Department of Mathematics and Statistics, Laboratory for Industrial and Applied Mathematics (LIAM), York University, Toronto, ON, Canada
  2. Department of Internal Medicine, Southern Hospital, Warsaw, Poland

open access

Vol 8, No 3 (2023)
LETTERS TO THE EDITOR
Published online: 2023-07-13

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

SARS-COV-2; COVID-19; nCOV; biomarker; prognosis; diagnosis; severity

About this article
Title

C-reactive protein and other biomarkers for diagnosis and prognosis in COVID-19

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 8, No 3 (2023)

Article type

Letter to the Editor

Pages

187-188

Published online

2023-07-13

Page views

140

Article views/downloads

149

DOI

10.5603/DEMJ.a2023.0023

Bibliographic record

Disaster Emerg Med J 2023;8(3):187-188.

Keywords

SARS-COV-2
COVID-19
nCOV
biomarker
prognosis
diagnosis
severity

Authors

Nicola Luigi Bragazzi
Karolina Czerwiec
Weronika Popow
Urszula Szafranska

References (9)
  1. Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020; 127: 104370.
  2. Ansari-Moghaddam B, Ahmadi S, Matouri M, et al. Screening role of complete blood cell count indices and C reactive protein in patients who are symptomatic for COVID-19. Disaster and Emergency Medicine Journal. 2022; 7(3): 176–181.
  3. Ruetzler K, Szarpak Ł, Ładny JR, et al. D-dimer levels predict COVID-19 severity and mortality. Kardiol Pol. 2021; 79(2): 217–218.
  4. Kilic M, Hokenek UD. Association between D-dimer and mortality in COVID-19 patients: a single center study from a Turkish hospital. Disaster and Emergency Medicine Journal. 2022; 7(4): 225–230.
  5. Fialek B, Pruc M, Smereka J, et al. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol J. 2022; 29(5): 751–758.
  6. Szarpak Ł, Nowak B, Kosior D, et al. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Pol Arch Intern Med. 2021; 131(1): 98–99.
  7. Szarpak L, Zaczynski A, Kosior D, et al. Evidence of diagnostic value of ferritin in patients with COVID-19. Cardiol J. 2020; 27(6): 886–887.
  8. Sabbatinelli J, Matacchione G, Giuliani A, et al. Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes. Mech Ageing Dev. 2022; 204: 111667.
  9. Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, et al. Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19. Front Immunol. 2022; 13: 857573.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl